New drugs in multiple myeloma and the significance of autologous stem cell transplants.
Jagannath
Sundar
S
Multiple Myeloma Program, Bone Marrow and Stem Cell Transplantation Program, St. Vincent's Comprehensive Cancer Center, New York, NY 10011, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000628:therapy*; D009842:Oligopeptides / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009842:Oligopeptides; D013792:Thalidomide; C524865:carfilzomib; C467566:pomalidomide